Showing results (531-540 of 586) with videos related to
Sort By:
Pageof 59
Archives of Toxicology|April 2, 2003
Markers of experimental acute inflammation in the Wistar Han rat with particular reference to haptoglobin and C-reactive proteinP S Giffen, J Turton, C M Andrews, et al.Pediatric Pulmonology|March 23, 2010
Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis--a pilot randomized controlled trialAlan R Smyth, Paramita M Cifelli, Catharine A Ortori, et al.Pediatric Pulmonology|December 29, 2015
Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trialDoug L Forrester, Alan J Knox, Alan R Smyth, et al.Journal of Clinical Microbiology|April 7, 2017
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among EnterobacteriaceaeVirginia M Pierce, Patricia J Simner, David R Lonsway, et al.NIHR Open Research|August 14, 2024
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot studyChristabella Ng, Neele S Dellschaft, Caroline Hoad, et al.NIHR Open Research|October 26, 2023
A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator eraRebecca J Calthorpe, Natalie Goodchild, Vigilius Gleetus, et al.Frontiers in Physiology|April 14, 2023
Dual thick and thin filament linked regulation of stretch- and L-NAME-induced tone in young and senescent murine basilar arteryLubomir T Lubomirov, Mechthild M Schroeter, Veronika Hasse, et al.Journal of Clinical Microbiology|November 10, 2017
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumanniiPatricia J Simner, J Kristie Johnson, William B Brasso, et al.Nature Communications|February 8, 2023
Future therapies for cystic fibrosisLucy Allen, Lorna Allen, Siobhan B Carr, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 16, 2022
Preferred health outcome states following treatment for pulmonary exacerbations of cystic fibrosisCharlie McLeod, Jamie Wood, Siobhain Mulrennan, et al.Pageof 59